389 related articles for article (PubMed ID: 15952999)
1. Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
Mitchell CD; Richards SM; Kinsey SE; Lilleyman J; Vora A; Eden TO;
Br J Haematol; 2005 Jun; 129(6):734-45. PubMed ID: 15952999
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
3. No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol.
Igarashi S; Manabe A; Ohara A; Kumagai M; Saito T; Okimoto Y; Kamijo T; Isoyama K; Kajiwara M; Sotomatsu M; Sugita K; Sugita K; Maeda M; Yabe H; Kinoshita A; Kaneko T; Hayashi Y; Ikuta K; Hanada R; Tsuchida M
J Clin Oncol; 2005 Sep; 23(27):6489-98. PubMed ID: 16170158
[TBL] [Abstract][Full Text] [Related]
4. Which steroids should we choose for the treatment of adult acute lymphoblastic leukemia?
Zheng C; Liu X; Wu J; Cai X; Zhu W; Sun Z
Am J Hematol; 2010 Oct; 85(10):817-8. PubMed ID: 20815080
[TBL] [Abstract][Full Text] [Related]
5. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children's Cancer Study Group Study L99-15.
Manabe A; Ohara A; Hasegawa D; Koh K; Saito T; Kiyokawa N; Kikuchi A; Takahashi H; Ikuta K; Hayashi Y; Hanada R; Tsuchida M;
Haematologica; 2008 Aug; 93(8):1155-60. PubMed ID: 18519521
[TBL] [Abstract][Full Text] [Related]
6. Intravenous 6-mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922.
Tolar J; Bostrom BC; La MK; Sather HN
Pediatr Blood Cancer; 2005 Jul; 45(1):5-9. PubMed ID: 15481062
[TBL] [Abstract][Full Text] [Related]
7. The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers.
McNeer JL; Nachman JB
Br J Haematol; 2010 Jun; 149(5):638-52. PubMed ID: 20408842
[TBL] [Abstract][Full Text] [Related]
8. Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemia.
Petersen KB; Müller J; Rasmussen M; Schmiegelow K
Med Pediatr Oncol; 2003 Aug; 41(2):110-4. PubMed ID: 12825213
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
[TBL] [Abstract][Full Text] [Related]
10. Low incidence of CNS relapse with cranial radiotherapy and intrathecal methotrexate in acute lymphoblastic leukemia.
Raje NS; Vaidya SJ; Kapoor G; Pai SK; Nair CN; Kurkure PA; Magrath IT; Advani SH
Indian Pediatr; 1996 Jul; 33(7):556-60. PubMed ID: 8979564
[TBL] [Abstract][Full Text] [Related]
11. Resistance to glucocorticoids in childhood acute lymphoblastic leukemia: impact of relationship between ex vivo sensitivity and in vivo concentration on risk factor analysis.
Styczynski J; Koltan A; Wysocki M
Neoplasma; 2006; 53(2):168-73. PubMed ID: 16575474
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of cortivazol in childhood acute lymphoblastic leukemia.
Styczynski J; Kurylak A; Wysocki M
Anticancer Res; 2005; 25(3B):2253-8. PubMed ID: 16158972
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia.
Pession A; Valsecchi MG; Masera G; Kamps WA; Magyarosy E; Rizzari C; van Wering ER; Lo Nigro L; van der Does A; Locatelli F; Basso G; Aricò M
J Clin Oncol; 2005 Oct; 23(28):7161-7. PubMed ID: 16192600
[TBL] [Abstract][Full Text] [Related]
14. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia.
Elmantaser M; Stewart G; Young D; Duncan R; Gibson B; Ahmed SF
Arch Dis Child; 2010 Oct; 95(10):805-9. PubMed ID: 20576660
[TBL] [Abstract][Full Text] [Related]
15. Circumvention of glucocorticoid resistance in childhood leukemia.
Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253
[TBL] [Abstract][Full Text] [Related]
16. Short-term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukaemia.
Wallace AM; Tucker P; Williams DM; Hughes IA; Ahmed SF
Clin Endocrinol (Oxf); 2003 Jun; 58(6):770-6. PubMed ID: 12780755
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test.
Rix M; Birkebaek NH; Rosthøj S; Clausen N
J Pediatr; 2005 Nov; 147(5):645-50. PubMed ID: 16291357
[TBL] [Abstract][Full Text] [Related]
18. Comparison between single-dose oral prednisolone and oral dexamethasone in the treatment of croup: a randomized, double-blinded clinical trial.
Fifoot AA; Ting JY
Emerg Med Australas; 2007 Feb; 19(1):51-8. PubMed ID: 17305661
[TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
20. [Is there a risk of steroid-induced adrenal deficit after induction treatment of acute lymphoblastic leukemia?].
Bélien-Pallet V; Cabrol S; Fasola S; Petit A; Landman-Parker J; Auvrignon A; Leverger G
Arch Pediatr; 2010 Dec; 17(12):1637-44. PubMed ID: 20943354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
